M & A wrap: Luminex being bought for $1.8B, M-Files makes a buy

Here are two recent deals that caught our attention. • Luminex Corp. — an Austin-based company making biological testing equipment that can screen for many diseases, including Covid-19 — is being bought by Italian diagnostics company DiaSorin SpA for about $1.8 billion. The companies announced the deal April 11. DiaSorin agreed to pay $37 a s hare in cash, a roughly 12% premium compared with Luminex’s closing price of $32.95 on April 9. That also represents a premium of 23% compared with…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news